Skip to content

Treatment of Rheumatoid Hand With Magnetotherapy

Type of Magnetic Field and the Effects of Rheumatoid Arthritis Treatment

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05920746
Enrollment
72
Registered
2023-06-27
Start date
2021-03-01
Completion date
2023-01-05
Last updated
2023-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hand Rheumatism, Rheumatoid Arthritis

Keywords

Magnetotherapy, Rheumatoid arthritis, Hand function

Brief summary

Brief Summary: Participants with rheumatoid arthritis with recommendation to physiotherapy. Created 2 study groups: 1. Kinesiotherapy with static magnetic field 2. Kinesiotherapy with low-frequency pulsed magnetic field Pulsed magnetic field give better effects then static magnetic field.

Detailed description

Participants with rheumatoid arthritis with recommendation to physiotherapy. All participants have dysfunction and pain of hand. Before entering the study, all patients were examined by a rheumatologist, who determined the degree of radiological and functional changes and measured blood pressure. Patients with II° and III° of radiological and functional changes were qualified for the study. All the patients gave their informed consent to participate in the study. The examination included an overall assessment of functional status. Patients were examined immediately before and after the intervention.

Interventions

Individual kinesiotherapy. Parameters of magnetic field: 7 mT, f= 10-20 Hz, type of impulse: bipolar, rectangular pulse

Sponsors

Jolanta Zwolińska
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

Assessor evaluating the patients' condition had no knowledge of the outcome of randomization of patients to the study groups.

Eligibility

Sex/Gender
ALL
Age
35 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. Informed voluntary consent to participate in the study 2. II ° and III ° of advancement of radiological changes 3. II ° and III ° of advancement of functional changes 4. Remission, low or moderate RA activity: DAS28 5. Medical referral for physiotherapy treatment

Exclusion criteria

1. Additional physiotherapy treatments for the hands 2. Contraindications for magnetotherapy treatments 3. Lack of informed, voluntary consent to participate in the study

Design outcomes

Primary

MeasureTime frameDescription
Visual Analogue ScaleChange from baseline VAS value immediately after therapy.Pain severity rating scale. only one value. Minimum value is 0, maximum value is 10. The best is 0, the worst is 10.
Health Assesment QuestionaireChange from baseline HAQ-20 value immediately after therapy.Subjective assesment of level of disability. Value of each of 8 subsections: minimum value 0, maximum value 3. total score is averaged. The best total score is 0, the worst is 3.
Range of motionChange from baseline range of motion value immediately after therapy.Computerized measurement of the range of motion of the joints of the hand \[mm\]. A higher score value meant a greater range of motions.
Displacement hand volume measurementChange from baseline volume value immediately after therapy.Measurement of hand volume using the displacement method \[mm3\]. The higher score means less swelling.
Persistence time of morning stiffnessChange from baseline time of morning stiffness value immediately after therapy.Patient's subjective assessment of the duration of morning stiffness \[min\]. The longer durations means more hand dysfunction.
Severity of morning stiffnessChange from baseline time of severity of morning stiffness value immediately after therapy.Assessing the severity of morning stiffness using a 100-point scale. The higher score means a greater severity of morning stiffness.

Countries

Poland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026